Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bluebird Bio
Biotech
Private equity firms take over bluebird's nest—Chutes & Ladders
Private equity firms take over bluebird’s nest. Novartis vet vaults to FoRx. Indivior IDs next CEO.
Darren Incorvaia
,
Zoey Becker
Feb 28, 2025 8:30am
BIO, Seaport, Orna and more—Chutes & Ladders
Apr 12, 2024 8:30am
Ex-bluebird execs hope to fly startup to delivery tech heights
Apr 9, 2024 7:00am
ASH: Editas shares data for mid-stage sickle cell disease asset
Dec 11, 2023 2:33pm
Bluebird closer to lovo-cel approval after FDA smooths path
Aug 16, 2023 9:59am
New year, new C-suite execs—Chutes & Ladders
Jan 6, 2023 9:30am
